MARK BOGUNIEWICZ
Allopathic & Osteopathic Physicians|Allergy & Immunology|Allergy DENVER, CO NPI 1790796555
Browse related groups: Allopathic & Osteopathic Physicians|Allergy & Immunology|Allergy CO Dermavant Sciences, Inc. All categories
General Payments — all program years on this page
$1,090,887.57
- Category: General Payments
- Program years: PY2018–2024
- Record count: 915
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $85,944.99 across 69 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $51,855.07 | 14 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,263.00 | 1 |
| Travel and Lodging | $14,000.19 | 21 |
| Honoraria | $3,375.00 | 1 |
| Food and Beverage | $2,451.73 | 32 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Dermavant Sciences, Inc. | $29,132.69 | 35 |
| GENZYME CORPORATION | $27,270.34 | 8 |
| GlaxoSmithKline, LLC. | $6,000.00 | 1 |
| Amgen Inc. | $5,902.50 | 6 |
| Eli Lilly and Company | $4,769.43 | 8 |
| Arcutis Biotherapeutics, Inc. | $3,629.39 | 6 |
| PFIZER INC. | $3,375.00 | 1 |
| Incyte Corporation | $3,168.78 | 1 |
| Regeneron Healthcare Solutions, Inc. | $2,584.00 | 1 |
| ABBVIE INC. | $88.96 | 1 |
| LEO Pharma Inc. | $23.90 | 1 |
By program year
Records — PY2024 (69)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.